Repurposing FDA Approved Drugs to Use for Ovarian Cancer
New treatments are overdue
The treatments that we have today aren't very good, with about 70% of women with ovarian cancer dying within 5 years of their diagnosis. First author Dr. Anil Belur Nagaraj, a research associate from Case Western Reserve University School of medicine, explains that the time and money required to develop new drugs contributes to this delay in discovering new treatments.
